Company Anomis Pharma Plus Srl with Fiscal Code 27365831
recorded a turnover of 2024 of
1.580.281,
with a net profit of
164.704
and having an average number of employees of
16.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Anomis Pharma Plus Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
169.264
493.802
667.588
722.601
826.169
1.059.085
1.021.113
1.238.444
1.336.561
1.580.281
Total Income - EUR
187.923
493.827
668.044
723.037
838.649
1.059.441
1.021.617
1.239.682
1.338.832
1.580.339
Total Expenses - EUR
189.766
471.095
634.229
697.671
787.836
977.100
925.240
1.067.704
1.196.129
1.388.357
Gross Profit/Loss - EUR
-1.844
22.732
33.815
25.366
50.812
82.341
96.377
171.979
142.703
191.982
Net Profit/Loss - EUR
-1.844
19.577
28.485
18.130
42.455
69.876
82.344
146.389
121.769
164.704
Employees
11
15
15
16
20
18
17
16
15
16
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 18.9%, from 1.336.561 euro in the year 2023, to 1.580.281 euro in 2024.
The Net Profit increased by 43.616 euro, from 121.769 euro in 2023, to 164.704 in the last year.
Check the financial reports for the company - Anomis Pharma Plus Srl
Financial Rating - ANOMIS PHARMA PLUS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Anomis Pharma Plus Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Anomis Pharma Plus Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Anomis Pharma Plus Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Anomis Pharma Plus Srl - CUI 27365831
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
563
58.706
36.989
24.732
90.364
76.856
79.264
89.690
290.480
295.358
Current Assets
105.238
219.125
281.252
353.903
363.063
387.907
487.655
630.941
563.258
745.747
Inventories
52.465
129.247
172.625
197.277
252.363
223.491
275.634
382.698
382.040
369.178
Receivables
33.357
43.253
74.596
96.822
89.831
118.345
122.854
142.371
162.487
186.493
Cash
19.416
46.625
34.031
59.804
20.869
46.072
89.168
105.872
18.732
190.076
Shareholders Funds
33.049
31.883
59.829
76.860
117.831
185.336
263.569
367.989
488.642
650.615
Social Capital
22.542
2.271
2.233
2.192
2.154
2.113
2.066
2.072
2.066
2.055
Debts
72.753
245.947
258.412
302.042
335.596
279.427
303.350
352.642
365.097
390.490
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
745.747 euro in 2024 which includes Inventories of
369.178 euro, Receivables of
186.493 euro and cash availability of
190.076 euro.
The company's Equity was valued at
650.615 euro, while total Liabilities amounted to
390.490 euro.
Equity increased by 164.704 euro, from 488.642 euro in 2023, to 650.615 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Anomis Pharma Plus Srl